IHC staining for HMGB3, cleaved caspase 3, and γH2AX verified that HMGB3 knockdown promoted cell apoptosis and the DNA damage response in ovarian cancer with olaparib treatment (Fig. 7E, G). This evidence concerns the gene HMGB3 and ovarian carcinoma.